Net Loss of Transgene Biotek reported to Rs 0.71 crore in the quarter ended March 2025 as against net loss of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 60.00% to Rs 0.08 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.68 crore in the year ended March 2025 as against net loss of Rs 0.66 crore during the previous year ended March 2024. Sales rose 13.04% to Rs 0.26 crore in the year ended March 2025 as against Rs 0.23 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	0.08	0.05	60	0.26	0.23	13
OPM %	-675.00	-540.00	-	-430.77	-265.22	-
PBDT	-0.69	-0.25	-176	-0.58	-0.56	-4
PBT	-0.71	-0.27	-163	-0.68	-0.66	-3
NP	-0.71	-0.27	-163	-0.68	-0.66	-3

Powered by Capital Market - Live News